- Home
- CATX vs PSBD Comparison
CATX vs PSBD Comparison
Compare CATX & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CATX | PSBD |
|---|---|---|
| Founded | 1983 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 341.0M | 325.5M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CATX | PSBD |
|---|---|---|
| Price | $2.99 | $10.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 9 |
| Target Price | $12.11 | ★ $12.33 |
| AVG Volume (30 Days) | ★ 1.3M | 107.8K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 15.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.66 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.96 | $9.34 |
| 52 Week High | $6.16 | $14.43 |
Technical Indicators
Market Signals| Indicator | CATX | PSBD |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 60.44 |
| Support Level | $2.82 | $10.32 |
| Resistance Level | $4.27 | $11.08 |
| Average True Range (ATR) | 0.15 | 0.35 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 62.77 | 89.92 |
Price Performance
Historical ComparisonAbout CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.